In conclusion, we showed that TRPM2 silencing significantly ameliorated fibrosis and inflammation in the kidneys of mice with HFD/STZ-induced diabetes, and this effect was largely achieved by the inhibition of TGF-β1-activated JNK1 activation. Here, TRPM2 is linked to diabetes mellitus.